![Sevgi Gurkan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sevgi Gurkan
Fondateur chez
Perfuse Therapeutics, Inc.
Profil
Sevgi Gurkan is the founder of Perfuse Therapeutics, Inc., founded in 2018, holding the title of Chief Executive Officer & Director.
Dr. Gurkan currently works as a Venture Partner at OrbiMed Advisors Private Equity since 2018.
Dr. Gurkan earned a doctorate degree from Icahn School of Medicine at Mount Sinai in 2008.
Postes actifs de Sevgi Gurkan
| Sociétés | Poste | Début |
|---|---|---|
Perfuse Therapeutics, Inc.
 Perfuse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to improve blood flow in retina and reduce blindness | Fondateur | 01/01/2018 |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Private Equity Investor | 01/04/2018 |
Formation de Sevgi Gurkan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
88
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Icahn School of Medicine at Mount Sinai
 Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
Perfuse Therapeutics, Inc.
Perfuse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to improve blood flow in retina and reduce blindness | Health Technology |
